Innovative Arylimidazole-Fused Phytovirucides via Carbene-Catalyzed [3+4] Cycloaddition: Locking Viral Cell-To-Cell Movement by Out-Competing Virus Capsid-Host Interactions.
Chunle WeiChunni ZhaoJiao LiChunyi LiBao-An SongRunjiang SongPublished in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024)
The control of potato virus Y (PVY) induced crop failure is a challengeable issue in agricultural chemistry. Although many anti-PVY agents are designed to focus on the functionally important coat protein (CP) of virus, how these drugs act on CP to inactivate viral pathogenicity, remains largely unknown. Herein, a PVY CP inhibitor -3j (S) is disclosed, which is accessed by developing unusually efficient (up to 99% yield) and chemo-selective (> 99:1 er in most cases) carbene-catalyzed [3+4] cycloaddition reactions. Compound -3j bears a unique arylimidazole-fused diazepine skeleton and shows chirality-preferred performance against PVY. In addition, -3j (S) as a mediator allows ARG191 (R 191 ) of CP to be identified as a key amino acid site responsible for intercellular movement of virions. R 191 is further demonstrated to be critical for the interaction between PVY CP and the plant functional protein NtCPIP, enabling virions to cross plasmodesmata. This key step can be significantly inhibited through bonding with the -3j (S) to further impair pathogenic behaviors involving systemic infection and particle assembly. The study reveals the in-depth mechanism of action of antiviral agents targeting PVY CP, and contributes to new drug structures and synthetic strategies for PVY management.
Keyphrases
- amino acid
- single cell
- sars cov
- cell therapy
- risk assessment
- room temperature
- cancer therapy
- high resolution
- drug induced
- squamous cell carcinoma
- stem cells
- escherichia coli
- binding protein
- drug delivery
- high glucose
- pseudomonas aeruginosa
- staphylococcus aureus
- radiation therapy
- locally advanced
- cell wall
- human health
- combination therapy
- electronic health record